Clinical Trial Update: Tumor Kinase Inhibitor Concentrations Measured by PET [NA]

View source ↗

Summary

This clinical trial update reports PET-based measurements of tumor kinase inhibitor concentrations in patients with metastatic cancer and notes the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Disseminated Malignant Neoplasm | NA | Status: COMPLETED